Skip to content

Ritter 229-002

by Midmark Corporation

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00841709124846 UDI-DIDate27 Aug 2026ListedStatusListed GUDID: in commercial distribution

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade Name
Ritter
Generic Name
General examination/treatment chair, electric
Model / Ref / Catalog
229-002
Primary DI / UDI-DI
00841709124846
FDA Product Code
GBB
GMDN Term
General examination/treatment chair, electric
Device Class
Class I
Regulation Number
878.4960
GUDID distribution status
In Commercial Distribution
MRI Safety
MR Unsafe

Other devices from Midmark Corporation

See all devices from Midmark Corporation →

Properties

  • Premarket Exempt
  • Serial Number
  • Manufacturing Date

Other properties (11)

  • Sterile: No
  • Single Use: No
  • Implantable: No
  • Contains Latex: No
  • Prescription Use: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No
  • Lot / Batch Number: No
  • Expiration Date: No